All In MedTech

FDA Clearance Tracker · P160026-S011

LIFEPAK 20e defibrillator/monitor

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 25, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P160026-S011
Device name
LIFEPAK 20e defibrillator/monitor
Applicant location
Redmond, WA
Received
Aug 29, 2019
Decided
Nov 25, 2019
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P160026

Device type

Device class
Class III
Regulation
21 CFR 870.5310

Every decision under product code MKJ

FDA's approval statement

As written in FDA's record.

Approval for a new Microcontroller component, which is located on the Power PCBA, and associated supporting subcomponents on the PCBA.

Source documents

Other decisions for Physio-Control, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.